Aaronson KD - Search Results

1

Non-patient factors associated with infections in LVAD recipients: A scoping review.

Shore S, Pienta MJ, Watt TMF, Yost G, Townsend WA, Cabrera L, Fetters MD, Chenoweth C, Aaronson KD, Pagani FD, Likosky DS; Michigan Congestive Heart Failure Investigators. Shore S, et al. Among authors: aaronson kd. J Heart Lung Transplant. 2022 Jan;41(1):1-16. doi: 10.1016/j.healun.2021.10.006. Epub 2021 Oct 22. J Heart Lung Transplant. 2022. PMID: 34801350 Free PMC article. Review.

2

Extracorporeal life support to left ventricular assist device bridge to heart transplant: A strategy to optimize survival and resource utilization.

Pagani FD, Lynch W, Swaniker F, Dyke DB, Bartlett R, Koelling T, Moscucci M, Deeb GM, Bolling S, Monaghan H, Aaronson KD. Pagani FD, et al. Among authors: aaronson kd. Circulation. 1999 Nov 9;100(19 Suppl):II206-10. doi: 10.1161/01.cir.100.suppl_2.ii-206. Circulation. 1999. PMID: 10567305

3

Assessment of an extracorporeal life support to LVAD bridge to heart transplant strategy.

Pagani FD, Aaronson KD, Dyke DB, Wright S, Swaniker F, Bartlett RH. Pagani FD, et al. Among authors: aaronson kd. Ann Thorac Surg. 2000 Dec;70(6):1977-84; discussion 1984-5. doi: 10.1016/s0003-4975(00)01998-6. Ann Thorac Surg. 2000. PMID: 11156106

4

LVAD therapy improves utilization of donor hearts: implications for prolonged inotropic therapy.

Aaronson K, Eppinger M, Wright S, Pagani FD. Aaronson K, et al. J Heart Lung Transplant. 2001 Feb;20(2):241. doi: 10.1016/s1053-2498(00)00544-1. J Heart Lung Transplant. 2001. PMID: 11250471 No abstract available.

5

The use of extracorporeal life support in adult patients with primary cardiac failure as a bridge to implantable left ventricular assist device.

Pagani FD, Aaronson KD, Swaniker F, Bartlett RH. Pagani FD, et al. Among authors: aaronson kd. Ann Thorac Surg. 2001 Mar;71(3 Suppl):S77-81; discussion S82-5. doi: 10.1016/s0003-4975(00)02620-5. Ann Thorac Surg. 2001. PMID: 11265871

6

Development of anti-major histocompatibility complex class I or II antibodies following left ventricular assist device implantation: effects on subsequent allograft rejection and survival.

Pagani FD, Dyke DB, Wright S, Cody R, Aaronson KD. Pagani FD, et al. Among authors: aaronson kd. J Heart Lung Transplant. 2001 Jun;20(6):646-53. doi: 10.1016/s1053-2498(01)00232-7. J Heart Lung Transplant. 2001. PMID: 11404170

7

Safety and efficacy of atorvastatin in heart transplant recipients.

Patel DN, Pagani FD, Koelling TM, Dyke DB, Baliga RR, Cody RJ, Lake KD, Aaronson KD. Patel DN, et al. Among authors: aaronson kd. J Heart Lung Transplant. 2002 Feb;21(2):204-10. doi: 10.1016/s1053-2498(01)00369-2. J Heart Lung Transplant. 2002. PMID: 11834348

8

Left ventricular assist device therapy improves utilization of donor hearts.

Aaronson KD, Eppinger MJ, Dyke DB, Wright S, Pagani FD. Aaronson KD, et al. J Am Coll Cardiol. 2002 Apr 17;39(8):1247-54. doi: 10.1016/s0735-1097(02)01751-5. J Am Coll Cardiol. 2002. PMID: 11955839 Free article.

9

Circulatory assist devices 2000: an update.

Dyke DB, Pagani FD, Aaronson KD. Dyke DB, et al. Among authors: aaronson kd. Congest Heart Fail. 2000 Sep-Oct;6(5):259-271. doi: 10.1111/j.1527-5299.2000.80165.x. Congest Heart Fail. 2000. PMID: 12189287 Free article.

10

Autologous skeletal myoblasts transplanted to ischemia-damaged myocardium in humans. Histological analysis of cell survival and differentiation.

Pagani FD, DerSimonian H, Zawadzka A, Wetzel K, Edge AS, Jacoby DB, Dinsmore JH, Wright S, Aretz TH, Eisen HJ, Aaronson KD. Pagani FD, et al. Among authors: aaronson kd. J Am Coll Cardiol. 2003 Mar 5;41(5):879-88. doi: 10.1016/s0735-1097(03)00081-0. J Am Coll Cardiol. 2003. PMID: 12628737 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

215 results

Search Page